Approval of the first U.S. transcatheter aortic heart valve came slightly later than Edwards Lifesciences anticipated, but Sapien will reach the market just in time for a highly anticipated debut at the Transcatheter Cardiovascular Therapeutics annual meeting in San Francisco this week.
Edwards Lifesciences gained FDA approval Nov. 2 for its Sapien transcatheter valve for severe aortic stenosis patients deemed too sick or frail for open heart surgery, and immediately launched the...
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
